Electronic messaging intervention for management of cardiovascular risk factors in type 2 diabetes mellitus: A randomised controlled trial

By  

JOURNAL OF CLINICAL NURSING, Vol. 27, Iss. 3-4, 2018-02 ,pp. : 612-620

John Wiley & Sons Inc

Access to resources Recommend Favorite

A risk score including body mass index, glycated haemoglobin and triglycerides predicts future glycaemic control in people with type 2 diabetes

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 3, 2018-03 ,pp. : 681-688

John Wiley & Sons Inc

Access to resources Recommend Favorite

Peri‐operative management of patients with type‐2 diabetes mellitus undergoing non‐cardiac surgery using liraglutide, glucose–insulin–potassium infusion or intravenous insulin bolus regimens: a randomised controlled trial

By  

ANAESTHESIA, Vol. 73, Iss. 3, 2018-03 ,pp. : 332-339

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus: meta-analysis of randomised controlled trials

By Allemann Sabin   Diem Peter   Egger Matthias   Christ Emanuel R.   Stettler Christoph  

Current Medical Research and Opinion, Vol. 22, Iss. 3, 2006-03 ,pp. : 617-623

Informa Healthcare

Access to resources Recommend Favorite

Diagnosing type 2 diabetes and identifying high-risk individuals using the new glycated haemoglobin (HbA1c) criteria

By Leach Mick   Evans Philip H   Pereira Gray Denis J   Wright Christine   Langley Peter  

British Journal of General Practice, Vol. 63, Iss. 610, 2013-05 ,pp. : 235-235

Royal College of General Practitioners

Access to resources Recommend Favorite